Barclays PLC lowered its holdings in DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 1.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 292,141 shares of the company’s stock after selling 4,488 shares during the period. Barclays PLC owned about 0.14% of DocuSign worth $18,139,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Thrivent Financial for Lutherans acquired a new position in shares of DocuSign during the 2nd quarter worth about $115,795,000. Pacer Advisors Inc. boosted its position in DocuSign by 77.9% during the second quarter. Pacer Advisors Inc. now owns 3,519,969 shares of the company’s stock valued at $188,318,000 after purchasing an additional 1,541,816 shares during the last quarter. KBC Group NV grew its stake in DocuSign by 209.8% in the third quarter. KBC Group NV now owns 1,156,874 shares of the company’s stock valued at $71,830,000 after purchasing an additional 783,419 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of DocuSign by 18.3% during the 2nd quarter. Renaissance Technologies LLC now owns 3,729,314 shares of the company’s stock worth $199,518,000 after purchasing an additional 576,414 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ raised its stake in shares of DocuSign by 151.3% during the 2nd quarter. Skandinaviska Enskilda Banken AB publ now owns 865,872 shares of the company’s stock worth $46,324,000 after purchasing an additional 521,292 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on DOCU shares. Royal Bank of Canada restated a “sector perform” rating and set a $90.00 target price (up from $57.00) on shares of DocuSign in a report on Friday, December 6th. Jefferies Financial Group boosted their price objective on shares of DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a report on Friday, December 6th. Hsbc Global Res upgraded DocuSign to a “moderate sell” rating in a report on Friday, December 6th. Finally, Bank of America upped their price objective on DocuSign from $60.00 to $68.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $92.45.
Insider Transactions at DocuSign
In other news, Director Daniel D. Springer sold 581,588 shares of DocuSign stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $97.04, for a total value of $56,437,299.52. Following the completion of the sale, the director now directly owns 906,430 shares in the company, valued at approximately $87,959,967.20. The trade was a 39.08 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Robert Chatwani sold 14,799 shares of the stock in a transaction that occurred on Wednesday, September 18th. The stock was sold at an average price of $55.46, for a total value of $820,752.54. Following the sale, the insider now directly owns 70,748 shares in the company, valued at $3,923,684.08. This represents a 17.30 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 651,184 shares of company stock valued at $60,878,829. 1.66% of the stock is currently owned by corporate insiders.
DocuSign Price Performance
DOCU opened at $94.48 on Friday. The business has a fifty day simple moving average of $78.04 and a 200 day simple moving average of $63.38. DocuSign, Inc. has a 1 year low of $48.70 and a 1 year high of $107.86. The company has a market capitalization of $19.09 billion, a PE ratio of 19.48, a price-to-earnings-growth ratio of 8.72 and a beta of 0.92.
DocuSign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
- Five stocks we like better than DocuSign
- 10 Best Airline Stocks to Buy
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Use Stock Screeners to Find Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Stock Splits, Do They Really Impact Investors?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.